In an increasingly global pharmaceutical supply chain, the COVID-19 outbreak has posed an existential challenge to an industry working across national borders. The virus has already shut down some production in China and affected exports of some active pharmaceutical ingredients from India. With access strained, cost inevitably increases.
A few key questions:
In this Fierce Pharma webcast, Leon Wyszkowski, President, Commercial Operations, and other experts discussed how to navigate the current global supply chain challenges.